- Home
- PRI vs AXSM Comparison
PRI vs AXSM Comparison
Compare PRI & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRI | AXSM |
|---|---|---|
| Founded | 1927 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 10.4B |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PRI | AXSM |
|---|---|---|
| Price | $290.67 | $213.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $294.00 | $211.12 |
| AVG Volume (30 Days) | 160.4K | ★ 515.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | ★ 67.10 | 38.56 |
| EPS | ★ 12.42 | N/A |
| Revenue | ★ $3,291,713,000.00 | N/A |
| Revenue This Year | $3.98 | $57.24 |
| Revenue Next Year | $5.08 | $55.88 |
| P/E Ratio | $23.38 | ★ N/A |
| Revenue Growth | ★ 6.56 | N/A |
| 52 Week Low | $230.09 | $114.91 |
| 52 Week High | $327.28 | $260.19 |
Technical Indicators
Market Signals| Indicator | PRI | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 46.30 | 52.47 |
| Support Level | $286.85 | $206.94 |
| Resistance Level | $300.06 | $222.93 |
| Average True Range (ATR) | 4.25 | 7.27 |
| MACD | 0.52 | 1.53 |
| Stochastic Oscillator | 55.51 | 55.86 |
Price Performance
Historical ComparisonAbout PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.